As of 09-Oct-2026
2QCY26 · PKR amounts, EPS/DPS per share · YoY
Keep the current chart as the default, or switch to TradingView for advanced tools.
Prices adjusted for bonuses & splits
Revenue
Rs 14.5B
6MCY26: Rs 31.5B (+4.0%)
Net profit
Rs 2.0B
6MCY26: Rs 4.6B (+9.2%)
EPS
Rs 6.19
6MCY26: Rs 14.39 (+9.2%)
DPS
Rs 7.00
6MCY26: Rs 7.00 (+40.0%)
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
Choose a section to view its metrics and trend.
Closely held shares
254.77M (80.00%)
Free Float shares
63.69M (20.00%)
Market Cap
100.83B
#1 of 14 in Pharmaceuticals Companies
More announcements are available in the full announcements tab.
Fundamental metrics to determine fair value of the stock
P/E History
Companies ranked closest to GLAXO by market capitalisation among the 14 companies in the Pharmaceuticals sector.
| SymbolCompany | Price (PKR) | Market cap | P/E | Dividend yield |
|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan (this stock) | 316.6 | Rs 100.8B | 9.6x | 6.0% |
| ABOT Abbott Laboratories (Pakistan | 926.5 | Rs 90.7B | 10.5x | 4.3% |
| HALEON Haleon Pakistan | 685.4 | Rs 80.2B | 12.1x | 4.4% |
| HINOON Highnoon Laboratories | 929.1 | Rs 49.2B | 11.8x | 5.4% |
| SEARL The Searle Company | 77.86 | Rs 45.8B | 104.4x | - |
| AGP AGP | 155.48 | Rs 43.5B | 11.9x | 5.1% |
| HPL Hoechst Pakistan | 3,961.82 | Rs 38.2B | 10.1x | 6.8% |
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc). GlaxoSmithKline Pakistan Limited (GLAXO) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 index. It is marked Shariah-compliant on the KMI screening.
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
GlaxoSmithKline Pakistan Limited (GLAXO) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 index. It is marked Shariah-compliant on the KMI screening.
Market data on FinHisaab is delayed and dates are shown where a figure is time-sensitive. This page is for information only and is not investment advice.
Use FinHisaab's screener and focused landing pages to compare GLAXO with dividend stocks, undervalued ideas, and KSE-100 companies across the Pakistan Stock Exchange.
